Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Palisade Bio, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −2 vs. Q1 2025
- Shares held
- 84.6K
- −211.7K (−71.5%) vs. Q1 2025
- Total value
- $57.5K
- −$143.4K (−71.4%) vs. Q1 2025
- New holders
- 3
- 2 more added
- Sold out
- 5
- 3 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PALI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $362.4M |
| Q1 2026 | 96 | $261.7M |
| Q4 2025 | 86 | $319.4M |
| Q3 2025 | 12 | $102.8K |
| Q2 2025 | 11 | $57.5K |
| Q1 2025 | 13 | $200.9K |
| Q4 2024 | 10 | $387.7K |
| Q3 2024 | 9 | $347.4K |
| Q2 2024 | 8 | $297.7K |
| Q1 2024 | 16 | $384.6K |
| Q4 2023 | 16 | $158.3K |
| Q3 2023 | 13 | $86.6K |
| Q2 2023 | 11 | $228.7K |
| Q1 2023 | 9 | $29.8K |
| Q4 2022 | 12 | $648.0K |
| Q3 2022 | 33 | $842.0K |
| Q2 2022 | 26 | $395.0K |
| Q1 2022 | 25 | $930.0K |
| Q4 2021 | 28 | $1.70M |
| Q3 2021 | 22 | $2.03M |
| Q2 2021 | 23 | $10.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Palisade Bio, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 27,337 | $18.6K | 0.00% | +27,337 | New |
| Geode Capital Management, LLC | 24,732 | $16.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 15,969 | $10.9K | 0.00% | +1,816+12.8% | Added |
| Newbridge Financial Services Group, Inc. | 10,500 | $7.14K | 0.00% | +10,500 | New |
| Tower Research Capital LLC (TRC) | 4,567 | $3.11K | 0.00% | −3−0.1% | Reduced |
| Transce3nd, LLC | 1,000 | $680 | 0.00% | +1,000 | New |
| UBS Group AG | 332 | $226 | 0.00% | −37,751−99.1% | Reduced |
| Federation des caisses Desjardins du Quebec | 100 | $68 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 45 | $31 | 0.00% | +22+95.7% | Added |
| Wells Fargo & Company | 21 | $14 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7 | $5 | 0.00% | −621−98.9% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −144,764−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −35,759−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,264−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,255−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |